Intract Pharma

Intract Pharma Limited is an oral drug delivery licensing and product development company offering a range of proprietary formulation technologies to deliver novel and optimised therapeutics targeted to patient needs. The company is a spin-out of University College London, and is centred around over 15 years of research and innovation from the laboratory of Professor Abdul Basit. Intract's range of formulation technologies includes Phloral™ for colon targeted delivery, and ProRelease™, a versatile microparticulate delivery system.

Dr Bill Lindsay
CEO 

Karma Oncology

Karma Oncology is an oncology specialized clinical research organisation. With a team of very experienced oncology project managers, CRAs and CTAs we offer all clinical trial services from preparation of clinical development plans including protocol design, project/study management, monitoring, data review, preparation of the clinical study report and manuscript. Services are customised to individual sponsors and as such we will perform any single aspect of a trial as efficiently and with the same enthusiasm and dedication as we will for the complete trial.

Dr Karen Williams
President 

Phastar

PHASTAR is a specialist CRO offering statistical consultancy, clinical trial reporting and data management services by providing expert consultants and delivering in-house projects. Our number one priority is to ensure that the work we produce is of the highest quality: every project PHASTAR undertakes is supervised on methodology and utilises internal processes designed to ensure optimal quality. Services include production of clinical study reports including generating tables, figures and listings; study design and protocol writing; modelling and simulation; and advice on handling missing data across phase I to IV trials. Our headquarters is in Chiswick, London (UK) with additional offices across four continents. We partner with pharmaceutical and biotech companies globally.

Website:
www.phastar.com
Mr Edward Clark
Business Development 

Plasticell Limited

Plasticell is a biotechnology company that develops novel therapies through precise manipulation of stem cells and more differentiated cell types using award-winning combinatorial screening technology.

Dennis Saw